Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael G Palazzolo

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
International Journal of Epidemiology|June 17, 2025
Estimating and presenting non-linear associations with restricted cubic splinesAndrea Discacciati, Michael G Palazzolo, Jeong-Gun Park, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 26, 2022
Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trialSiddharth M Patel, Michael G Palazzolo, Sabina A Murphy, et al.
International Journal of Cardiology|May 21, 2023
Neutrophil-lymphocyte ratio and clinical outcomes in 19,697 patients with atrial fibrillation: Analyses from ENGAGE AF- TIMI 48 trialAntonio Fagundes, Christian T Ruff, David A Morrow, et al.
European Journal of Internal Medicine|February 19, 2026
Major adverse cardiovascular and bleeding outcomes in paroxysmal vs. non-paroxysmal atrial fibrillation: an individual patient-level data analysis of a large cohort of patients from the COMBINE-AFGeorge Ntaios, Andreas Goette, Michael G Palazzolo, et al.
JAMA Cardiology|July 10, 2024
Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation: Post Hoc Analysis of the ENGAGE AF-TIMI 48 Randomized Clinical TrialAndré Zimerman, Eugene Braunwald, Jan Steffel, et al.
Circulation|August 25, 2023
Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral AnticoagulantsRahul Aggarwal, Christian T Ruff, Saverio Virdone, et al.
Journal of the American Heart Association|October 28, 2025
Contemporary Practice Patterns of Vasoactive Use in Cardiogenic Shock in the American Heart Association Cardiogenic Shock RegistrySiddharth M Patel, David D Berg, Erin A Bohula, et al.
Circulation|January 30, 2026
Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71 683 Participants Randomized to NOAC Versus WarfarinSamer Al Said, Eugene Braunwald, Michael G Palazzolo, et al.
American Heart Journal|June 23, 2026
DOAC Score Among Patients Receiving Vitamin K AntagonistsRahul Aggarwal, Christian T Ruff, Michael G Palazzolo, et al.
European Heart Journal|April 30, 2026
Direct oral anticoagulants vs warfarin in Asian vs non-Asian patients with atrial fibrillation: a patient-level meta-analysis from COMBINE AFTze-Fan Chao, Eugene Braunwald, Michael G Palazzolo, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
International Journal of Epidemiology|June 17, 2025
Estimating and presenting non-linear associations with restricted cubic splinesAndrea Discacciati, Michael G Palazzolo, Jeong-Gun Park, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 26, 2022
Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trialSiddharth M Patel, Michael G Palazzolo, Sabina A Murphy, et al.
International Journal of Cardiology|May 21, 2023
Neutrophil-lymphocyte ratio and clinical outcomes in 19,697 patients with atrial fibrillation: Analyses from ENGAGE AF- TIMI 48 trialAntonio Fagundes, Christian T Ruff, David A Morrow, et al.
European Journal of Internal Medicine|February 19, 2026
Major adverse cardiovascular and bleeding outcomes in paroxysmal vs. non-paroxysmal atrial fibrillation: an individual patient-level data analysis of a large cohort of patients from the COMBINE-AFGeorge Ntaios, Andreas Goette, Michael G Palazzolo, et al.
JAMA Cardiology|July 10, 2024
Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation: Post Hoc Analysis of the ENGAGE AF-TIMI 48 Randomized Clinical TrialAndré Zimerman, Eugene Braunwald, Jan Steffel, et al.
Circulation|August 25, 2023
Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral AnticoagulantsRahul Aggarwal, Christian T Ruff, Saverio Virdone, et al.
Journal of the American Heart Association|October 28, 2025
Contemporary Practice Patterns of Vasoactive Use in Cardiogenic Shock in the American Heart Association Cardiogenic Shock RegistrySiddharth M Patel, David D Berg, Erin A Bohula, et al.
Circulation|January 30, 2026
Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71 683 Participants Randomized to NOAC Versus WarfarinSamer Al Said, Eugene Braunwald, Michael G Palazzolo, et al.
American Heart Journal|June 23, 2026
DOAC Score Among Patients Receiving Vitamin K AntagonistsRahul Aggarwal, Christian T Ruff, Michael G Palazzolo, et al.
European Heart Journal|April 30, 2026
Direct oral anticoagulants vs warfarin in Asian vs non-Asian patients with atrial fibrillation: a patient-level meta-analysis from COMBINE AFTze-Fan Chao, Eugene Braunwald, Michael G Palazzolo, et al.
Pageof 2